sorenSøren Johan Brun

Senior Advisor
Read more about Søren

sorenSøren Johan Brun

Senior Advisor
Read more about Søren

sorenSøren Johan Brun

Senior Advisor
Read more about Søren

sorenSøren Johan Brun

Senior Advisor
Read more about Søren

sorenSøren Johan Brun

Senior Advisor
Read more about Søren

Skip to content
Gemstone Capital
Gemstone Capital
  • Home
  • IPO
  • M&A
  • Team
  • Newsroom
  • Contact us
  • Home
  • IPO
  • M&A
  • Team
  • Newsroom
  • Contact us

Daily Archives: 05/12/2021

Expres2ion Biotechnologies announces positive results for its covid-19 vaccine

IPO and M&ABy webmaster05/12/2021

Copenhagen, December 2021 “ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion”) announces that the ABNCoV2 vaccine demonstrated a strong boosting effect in the clinical Phase II trial conducted by Bavarian Nordic. ” Read more about the exciting news HERE. Expres2ion was Gemstone Capital’s first IPO (2016)

Go to Top

sdafasdfasf

Freetrailer Investormøde 22/05/18

sdafasdfasf

Freetrailer Investormøde 22/05/18
ST popup Team
Freetrailer Investormøde 22/05/18